1.72
+0.02(+1.18%)
Currency In USD
| Previous Close | 1.7 |
| Open | 1.69 |
| Day High | 1.75 |
| Day Low | 1.68 |
| 52-Week High | 5.24 |
| 52-Week Low | 1.67 |
| Volume | 7,934 |
| Average Volume | 44,253 |
| Market Cap | 70.72M |
| PE | -1.3 |
| EPS | -1.32 |
| Moving Average 50 Days | 2.36 |
| Moving Average 200 Days | 3.29 |
| Change | 0.02 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $118.62 as of May 24, 2025 at a share price of $1.72. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $283.83 as of May 24, 2025 at a share price of $1.72.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced it
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after marke
Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
GlobeNewswire Inc.
Apr 22, 2025 8:05 PM GMT
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participat